|
61 |
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy
Enthalten in BMC cancer Bd. 8, 26.2.2008, Nr. 1, date:12.2008: 1-10
|
|
|
|
62 |
Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
Enthalten in Breast cancer research Bd. 8, 24.10.2006, Nr. 5, date:10.2006: 1-7
|
|
|
|
63 |
Rare genital malformations in women’s health research: sociodemographic, regional, and disease-related characteristics of patients with Mayer-Rokitansky-Küster-Hauser syndrome
Enthalten in BMC women's health Bd. 20, 29.6.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
64 |
Return of individual genomic research results within the PRAEGNANT multicenter registry study
Enthalten in Breast cancer research and treatment Bd. 197, 21.11.2022, Nr. 2, date:1.2023: 355-368
|
|
|
|
65 |
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Enthalten in npj Breast cancer Bd. 10, 13.7.2024, Nr. 1, date:12.2024: 1-7
|
|
|
|
66 |
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Enthalten in BMC cancer Bd. 24, 16.10.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
67 |
The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
Enthalten in Breast cancer research Bd. 15, 8.10.2013, Nr. 5, date:10.2013: 1-10
|
|
Administration
